QbD Group, a Belgian-based company offering comprehensive support to Life Sciences companies, acquired a majority stake in Spain-based Azierta for an undisclosed consideration.
Azierta, based in Madrid, is a life sciences and health consulting firm focused on providing pharmacovigilance, regulatory affairs, audits and certifications, GxP compliance services, and scientific and medical affairs.
The acquisition is part of QbD Group's life sciences and health sector growth strategy. The transaction will enable QbD Group to strengthen its presence in Spain, where Azierta has a strong market penetration and brand recognition.
PKF Attest has been the financial advisor to the seller.
cloud technology axon
tuTECHÔ, empresa social que lucha contra el sinhogarismo en España, ...
Capital-Riesgo.es
Subscribe to our newsletter and stay up to date with the latest news and deals!
2013 © Capital-Riesgo.es - Site Developments SL. All Rights Reserved. Terms of Service | Privacy Policy
Articles
Directory